HealthEquity, Inc. (HQY) Stake Increased by BlackRock Institutional Trust Company N.A.

HealthEquity, Inc. (HQY) Stake Increased by BlackRock Institutional Trust Company N.A.

BlackRock Institutional Trust Company N.A. boosted its position in HealthEquity, Inc. (NASDAQ:HQY) by 11.4% during the third quarter, Holdings Channel reports. The firm owned 1,041,594 shares of the company’s stock after buying an additional 106,235 shares during the period. BlackRock Institutional Trust Company N.A. owned approximately 1.78% of HealthEquity worth $39,424,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in shares of HealthEquity by 26.3% in the second quarter. Vanguard Group Inc. now owns 3,150,828 shares of the company’s stock worth $95,739,000 after buying an additional 656,849 shares in the last quarter. BlackRock Fund Advisors raised its stake in shares of HealthEquity by 19.2% in the third quarter. BlackRock Fund Advisors now owns 3,123,191 shares of the company’s stock worth $118,213,000 after buying an additional 503,204 shares in the last quarter. Janus Capital Management LLC raised its stake in shares of HealthEquity by 1.4% in the second quarter. Janus Capital Management LLC now owns 2,658,688 shares of the company’s stock worth $80,784,000 after buying an additional 37,044 shares in the last quarter. Waddell & Reed Financial Inc. raised its stake in shares of HealthEquity by 59.1% in the second quarter. Waddell & Reed Financial Inc. now owns 1,008,110 shares of the company’s stock worth $30,632,000 after buying an additional 374,529 shares in the last quarter. Finally, State Street Corp raised its stake in shares of HealthEquity by 3.6% in the second quarter. State Street Corp now owns 898,019 shares of the company’s stock worth $27,285,000 after buying an additional 30,925 shares in the last quarter. Institutional investors and hedge funds own 91.25% of the company’s stock.

Shares of HealthEquity, Inc. (NASDAQ:HQY) traded down 0.32% during mid-day trading on Friday, reaching $47.38. 540,045 shares of the company’s stock traded hands. The company has a 50 day moving average of $43.63 and a 200 day moving average of $36.72. The company has a market cap of $2.81 billion, a price-to-earnings ratio of 112.81 and a beta of 1.91. HealthEquity, Inc. has a 12 month low of $15.80 and a 12 month high of $49.25.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, December 6th. The company reported $0.10 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.09 by $0.01. HealthEquity had a return on equity of 11.08% and a net margin of 15.19%. The business had revenue of $43.36 million for the quarter, compared to analysts’ expectations of $43.29 million. During the same period in the prior year, the business posted $0.08 earnings per share. The firm’s revenue was up 41.9% on a year-over-year basis. Analysts expect that HealthEquity, Inc. will post $0.42 earnings per share for the current fiscal year.

Several research analysts have recently issued reports on the stock. KeyCorp assumed coverage on shares of HealthEquity in a research note on Monday, January 23rd. They issued an “overweight” rating and a $60.00 target price on the stock. Chardan Capital assumed coverage on shares of HealthEquity in a research note on Tuesday, December 13th. They issued a “buy” rating and a $50.00 target price on the stock. Zacks Investment Research lowered shares of HealthEquity from a “hold” rating to a “sell” rating in a research note on Monday, December 12th. Finally, J P Morgan Chase & Co assumed coverage on shares of HealthEquity in a research note on Friday, October 28th. They issued an “overweight” rating and a $43.00 target price on the stock. One analyst has rated the stock with a sell rating, two have issued a hold rating and nine have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $40.50.

In other HealthEquity news, VP Darcy G. Mott sold 10,000 shares of the stock in a transaction that occurred on Tuesday, December 20th. The stock was sold at an average price of $40.12, for a total transaction of $401,200.00. Following the transaction, the vice president now directly owns 66,000 shares in the company, valued at approximately $2,647,920. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Matthew Sydney sold 25,000 shares of the stock in a transaction that occurred on Tuesday, November 1st. The stock was sold at an average price of $32.52, for a total value of $813,000.00. Following the transaction, the vice president now owns 2,600 shares in the company, valued at $84,552. The disclosure for this sale can be found here. Insiders sold 1,497,352 shares of company stock worth $66,565,723 over the last quarter. 29.00% of the stock is currently owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY).

Related posts

Leave a Comment